- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
💊
Dinakion MM
Injection
Generic Name
Phytomenadione
Manufacturer
Drug International Ltd.
Unit Price
2 mg ampoule: ৳ 19.99 (1 x 5: ৳ 99.95)
🔹 Indications
Dinakion MM (Vitamin K-1) is indicated in following indications-
🔹 Pharmacology
Dinakion MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Dosage & Administration
Dinakion MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Interaction
Dinakion MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Contraindications
Dinakion MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Side Effects
Dinakion MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Precautions & Warnings
Dinakion MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Storage Conditions
Dinakion MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔍 People also search for
Dinakion MM
Dinakion MM Injection used for
Dinakion MM side effects
Dinakion MM price
Dinakion MM dose
Dinakion MM Injection uses
Is Dinakion MM safe
Dinakion MM dosage
Dinakion MM alternative
Dinakion MM Bangladesh
Phytomenadione
Phytomenadione price Bangladesh
Injection price Bangladesh
Drug International Ltd.
medicine bd
💡 Frequently Asked Questions
Dinakion MM (Vitamin K-1) is indicated in following indications-
Prophylaxis and treatment of haemorrhagic disease in the newborn.
Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II,...
Dinakion MM (Vitamin K-1) is indicated in following indications-
Prophylaxis and treatment of haemorrhagic disease in the newborn.
Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II,...
Dinakion MM (Vitamin K-1) is indicated in following indications-
Prophylaxis and treatment of haemorrhagic disease in the newborn.
Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II,...
User Reviews
⭐
No reviews yet!
Be the first to share your experience.